For Aristotle, good habits lead to ethical self-development. The converse is also true. To this end, for Aristotle, having ...

Wine has been a central part of life in the Italian peninsula since prehistory; in fact, along with wheat and olive oil, it ...

Proficient Auto Logistics, Inc. (NASDAQ: PAL) (the 'Company” or 'Proficient”) today reported its financial results for the ...

FDA PDUFA goal date of August 15, 2025, for TNX‑102 SL for fibromyalgia: if approved by FDA, TNX‑102 SL would be the first ...

Throughout history, fantastic treasures from various cultures have been stolen or mysteriously gone missing. Often their ...

Pagaya Technologies Ltd. (NASDAQ: PGY) ("Pagaya", the "Company" or "we"), a global technology company delivering artificial ...

Detailed price information for Optimizerx Corp (OPRX-Q) from The Globe and Mail including charting and trades.

Posts steady recurring revenue growth and margin expansionTORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Altus Group Limited (ʺAltus Group” or“ ...

Q2 revenue of $29.2 million, increased 55% year-over-yearQ2 gross profit increased 59% year-over-year to $18.6 millionPaid down $4.5 million of principal on outstanding term loan during Q2Increased fu ...

“We’re thrilled to welcome Dr. Tarnoff to our Board during this pivotal phase of growth,” said Jim Corbett, Chief Executive Officer of AVITA Medical. “His leadership and expertise in clinical ...

Detailed price information for James River Gp HD (JRVR-Q) from The Globe and Mail including charting and trades.

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...